JP2011121885A5 - - Google Patents

Download PDF

Info

Publication number
JP2011121885A5
JP2011121885A5 JP2009279847A JP2009279847A JP2011121885A5 JP 2011121885 A5 JP2011121885 A5 JP 2011121885A5 JP 2009279847 A JP2009279847 A JP 2009279847A JP 2009279847 A JP2009279847 A JP 2009279847A JP 2011121885 A5 JP2011121885 A5 JP 2011121885A5
Authority
JP
Japan
Prior art keywords
foods
food
oral
pharmaceutical
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009279847A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011121885A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009279847A priority Critical patent/JP2011121885A/ja
Priority claimed from JP2009279847A external-priority patent/JP2011121885A/ja
Publication of JP2011121885A publication Critical patent/JP2011121885A/ja
Publication of JP2011121885A5 publication Critical patent/JP2011121885A5/ja
Pending legal-status Critical Current

Links

JP2009279847A 2009-12-09 2009-12-09 ペプチドｙｙ分泌促進剤 Pending JP2011121885A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009279847A JP2011121885A (ja) 2009-12-09 2009-12-09 ペプチドｙｙ分泌促進剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009279847A JP2011121885A (ja) 2009-12-09 2009-12-09 ペプチドｙｙ分泌促進剤

Publications (2)

Publication Number Publication Date
JP2011121885A JP2011121885A (ja) 2011-06-23
JP2011121885A5 true JP2011121885A5 (enExample) 2012-11-01

Family

ID=44286144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009279847A Pending JP2011121885A (ja) 2009-12-09 2009-12-09 ペプチドｙｙ分泌促進剤

Country Status (1)

Country Link
JP (1) JP2011121885A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5925569B2 (ja) * 2012-01-16 2016-05-25 花王株式会社 消化管ホルモン分泌調節剤
EP4449891A4 (en) * 2021-12-14 2025-09-24 Japan Tobacco Inc ORAL PRODUCT CONTAINING A LOW MOLECULAR WEIGHT ALGINIC ACID COMPOUND AND COMPOSITION FOR SAID PRODUCT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009057343A (ja) * 2007-09-03 2009-03-19 Kikkoman Corp ナトリウム吸収阻害組成物
JP5276930B2 (ja) * 2007-10-22 2013-08-28 花王株式会社 容器詰め飲料
JP2009215408A (ja) * 2008-03-10 2009-09-24 Kyosei Seiyaku Kk α−グルコシダーゼ阻害剤およびその製造方法

Similar Documents

Publication Publication Date Title
IL274602A (en) Pharmaceutical tablets containing eltrombopag olamine, methods for their preparation and use thereof in the preparation of medicaments for treating thrombocytopenia
EP1848432A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF PATHOLOGIES COMPRISING OBESITY, DIABETES, METABOLIC SYNDROMES, NEURODEGENERATIVE DISEASES, AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION
HUE035931T2 (hu) N-[2,4-bis(1,1-dimetiletil)-5-hidroxipenil]-1,4-dihidro-4-oxokinolin-3-karboxamid gyógyszerészeti készítménye és annak alkalmazása
SI2419097T1 (sl) Farmacevtski sestavek, ki vsebuje (1S)-1,5-anhidro-1-(5-(4-etoksibenzil)-2-metoksi-4-metilfenil)-1-tio-d- glukitol in metformin in njegove uporabe pri zdravljenju diabetesa
DE602004017510D1 (de) Medizinprodukt vom kapseltyp
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
IL216006A (en) Substituted aromatic compounds, pharmaceutical compositions comprising them and use thereof in the manufacture of medications
HUE037735T2 (hu) DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
EA201100621A1 (ru) Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
EP2464362A4 (en) PROBIOTIC PREPARATION TO PREVENT OR TREAT GASTROINTESTINAL DISORDERS IN DOGS
CL2007001778A1 (es) Compuestos derivados de 2-pirazinacarboxamida, antagonistas/agonistas inversos selectivos de cb1; proceso de preparacion; composiciones farmaceuticas; y uso para el tratamiento y/o profilaxis de trastornos de ingestion de comida, diabetes tipo ii y a
IT1391454B1 (it) Contenitore per prodotti fluidi, particolarmente farmaceutici, cosmetici, alimentari o simili
DK2227539T3 (da) Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær
EP4527855A3 (en) Stable igg4 based binding agent formulations
IT1391448B1 (it) "contenitore per prodotti fluidi, particolarmente farmaceutici, cosmetici, alimentari o simili
IL208463A (en) 2-Trotocyclic-Pirol compounds combined, pharmaceutical preparations containing them and their use in the prevention or treatment of diabetes or obesity
WO2009068708A8 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
DK2209527T3 (da) Farmaceutiske sammensætninger omfattende L-acidophilus og Bifidobacterium lactis til anvendelse i behandlingen af funktionel tarmsygdom
BRPI0819342A2 (pt) Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos.
BR112013030171A2 (pt) composição comestível, método para reduzir a amplitude de pico de glicose pós-prandial no sangue ou resposta glicêmica em uma pessoa não diabética, método para tratar uma pessoa com necessidade de tratamento para diabetes do tipo 2 e uso da composição
HUE043063T2 (hu) Gyógyászati termék és kezelés
IT1393560B1 (it) Contenitore per prodotti fluidi, particolarmente prodotti farmaceutici, cosmetici, medicali o simili
CL2013001164A1 (es) Composicion que contiene 2-metilpropanotioato de s-[2-([[1-(2-etilbutil)-ciclohexil]-carbonil]amino)fenilo] y croscarmelosa sodica; proceso de preparacion; tableta que la contiene; kit y uso en el tratamiento y prevencion de trastornos cardiovasculares.
IL193306A (en) Use of Enhanced Forms of Factor V in the Preparation of Medicines to Treat Hemostasis-Related Disorders and Isolated Nucleic Acid Molecules Encoded into These Enhanced Forms
EA201291294A1 (ru) Изомальтулоза для применения для усиления умственной деятельности